Our Clinical Bioanalysis services provide high-quality, reliable data to support pharmacokinetic (PK), pharmacodynamic (PD), and bioequivalence studies across all phases of drug development. We partner with pharmaceutical and biotech companies to deliver accurate, regulatory-compliant bioanalytical testing that informs critical decision-making and accelerates time-to-market.

Our capabilities include:

• Quantitative analysis of small and large molecules in biological matrices

• Method development, validation, and transfer under GLP/GCP standards

• LC-MS/MS and immunoassay-based platforms

• Sample management, stability testing, and data reporting

• Support for regulatory submissions (FDA, EMA, etc.)

With a focus on scientific excellence, quality assurance, and timely delivery, we help our clients generate the robust clinical evidence needed to ensure safety, efficacy, and regulatory compliance.